The study was double blind, meaning the research participants and the investigators did not know who was receiving what until the end of the study
doi: 10.1056/NEJMoa2107519 [DOI] [PubMed] [Google Scholar] 29.Inagaki N., et al., Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial
Possible effects can include nausea, vomiting, diarrhea, constipation, abdominal discomfort, or changes in appetite
Studies have shown that Semaglutide treatment in West Palm Beach, FL, can reduce the risk of major cardiovascular events, such as heart attack and stroke, in individuals with type 2 diabetes Semaglutide is typically administered once a week via injection, making it a convenient option for those who prefer less frequent dosing
These would contaminate your peptide and potentially cause infections